Temasek Still Avoiding Crypto After FTX Loss, Focuses on AI and Europe

Temasek crypto FTX

نظرة سريعة

Temasek Global Investments president Nagi Hamiyeh stated crypto investment remains off-limits due to regulatory uncertainty and the company's substantial loss from FTX.
The firm is increasing its AI exposure and investing in European luxury and industrials.

ملخص مُنشأ بالذكاء الاصطناعي

حجم الخط

Temasek Global Investments president Nagi Hamiyeh stated crypto investment remains off-limits due to regulatory uncertainty and the company's substantial loss from FTX. The firm is increasing its AI exposure and investing in European luxury and industrials.

Read the full article on CNBC

مواضيع ذات صلة

Temasek

مواضيعcrypto FTX AI artificial intelligence blockchain Europe

This article was originally published by CNBC.

أخبار ذات صلة

المزيد حول هذا الموضوعTemasek

يتطور·15 dk önce

PepsiCo Reports Mixed Quarterly Results Amidst Consumer Budget Tightening

PepsiCo reported mixed second-quarter results, with strong international demand offsetting struggles in its North American food and beverage divisions. CEO Ramon Laguarta cited tightening consumer budgets due to inflation as a key factor impacting domestic performance.

CNBC

يتطور·1 sa önce

Gas Prices Could Rise Amid Renewed Tensions with Iran

Gas prices may increase as President Trump signals the end of a U.S.-Iran ceasefire, potentially pushing the national average towards $4 a gallon. Financial planners advise drivers to review budgets and cut discretionary spending.

CNBC

يتطور·1 sa önce

Luxshare Precision Industry's Hong Kong IPO Falls on Debut

Luxshare Precision Industry, a major Apple supplier, saw its shares end lower on their Hong Kong trading debut Thursday, despite raising $3.09 billion in its IPO, the largest this year. The stock closed down 1.55% after opening lower.

CNBC

يتطور·2 sa önce

South Korea's Kospi Enters Bear Territory Amid AI Skepticism and Market Concentration

South Korea's Kospi stock index has fallen into bear market territory, down over 20% from its record high, due to global investor skepticism about AI plays and extreme market concentration in chipmakers Samsung Electronics and SK Hynix.

CNBC

مُلِح·3 sa önce

AstraZeneca Shares Tumble After Heart Disease Drug Trial Fails

AstraZeneca's stock dropped nearly 9% after its experimental heart disease drug, Wainua, failed to meet its primary target in a late-stage clinical trial. The drug, intended for transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), did not significantly reduce deaths or heart emergencies compared to a placebo.

CNBC

يتطور·4 sa önce

Luxshare Precision Industry Shares Dip on Hong Kong Debut After Record IPO

Luxshare Precision Industry's shares dropped over 5% in their Hong Kong trading debut Thursday, following its $3.09 billion IPO, the largest this year. The Apple supplier, already listed in Shenzhen, priced shares at HK$63.28, with the stock trading at HK$60 early on.

CNBC

المزيد حول هذا الموضوعTemasek